Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cytomegalovirus
New cytomegalovirus study findings have been reported by researchers at Virginia Commonwealth University, Medical College of Virginia Campus
April 23rd, 2008
Investigators publish new data in the report 'Human CMV vaccine trials: what if CMV caused a rash.' "There are no apparent biologic obstacles to immunization against fetal/placental infection with cytomegalovirus (CMV), and vaccine candidates have been developed. The major obstacles for a human CMV vaccine are difficulties associated with the design and execution of efficacy trials," scientists in the United States report. "These trials will be prolonged with difficulties in recruiting subjects, and hampered by several factors: First is a lack of public awareness of CMV, making recruitment into vaccine trials difficult. Second is that trials using fetal infection as an...
Source: Vaccine Weekly (2008-04-23)
|
